Yizi Jin

1.7k total citations · 1 hit paper
18 papers, 951 citations indexed

About

Yizi Jin is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yizi Jin has authored 18 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yizi Jin's work include Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Cancer Treatment Studies (4 papers). Yizi Jin is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Cancer Treatment Studies (4 papers). Yizi Jin collaborates with scholars based in China, United States and Poland. Yizi Jin's co-authors include Mingxi Lin, Jian Zhang, Cheng Zeng, Xinyu Chen, Teng Zhou, Xin Shen, Xiaomin Ye, Qing Guo, Xichun Hu and Xuelei Ma and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Cancer.

In The Last Decade

Yizi Jin

17 papers receiving 942 citations

Hit Papers

NF-κB in biology and targeted therapy: new insights and t... 2024 2026 2025 2024 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NF-κB in biology and targeted therapy: new insights and translational implications
    2024 799 citations Qing Guo, Yizi Jin et al. Signal Transduction and Targeted Therapy profile →

Peers

Yizi Jin
Tingting Long China
Cheng Zeng China
Hui Guo China
Hsin‐Yu Fang United States
Te‐Mao Li Taiwan
Caixia Sun China
Pei‐Ling Chi Taiwan
Xiong Li China
Blake M. Warner United States
Tingting Long China
Yizi Jin
Citations per year, relative to Yizi Jin Yizi Jin (= 1×) peers Tingting Long

Countries citing papers authored by Yizi Jin

Since Specialization
Citations

This map shows the geographic impact of Yizi Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yizi Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yizi Jin more than expected).

Fields of papers citing papers by Yizi Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yizi Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yizi Jin. The network helps show where Yizi Jin may publish in the future.

Co-authorship network of co-authors of Yizi Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Yizi Jin. A scholar is included among the top collaborators of Yizi Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yizi Jin. Yizi Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chen, Xiaojing, Mingxi Lin, Yizi Jin, et al.. (2025). Overcoming matrix barriers for enhanced immune infiltration using siRNA-coated metal-organic frameworks. Acta Biomaterialia. 196. 410–422. 3 indexed citations
2.
Guo, Qing, Yizi Jin, Xinyu Chen, et al.. (2024). NF-κB in biology and targeted therapy: new insights and translational implications. Signal Transduction and Targeted Therapy. 9(1). 53–53. 799 indexed citations breakdown →
3.
Jin, Yizi, et al.. (2024). NF-κB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges. Life Sciences. 348. 122684–122684. 12 indexed citations
4.
5.
Jin, Yizi, Yiqun Du, Yanchun Meng, et al.. (2024). Results and exploratory biomarker analyses of a phase II study CHANGEABLE: Combination of HX008 and niraparib in germ-line-mutated metastatic breast cancer.. Journal of Clinical Oncology. 42(16_suppl). 1084–1084. 2 indexed citations
6.
Li, Huiyue, Jennifer K. Plichta, Kan Li, et al.. (2023). Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis. Breast Cancer Research and Treatment. 204(1). 89–105. 10 indexed citations
7.
Luo, Ting, Yizi Jin, Xiaorong Zhong, et al.. (2023). HER2‐low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis. Cancer. 130(6). 851–862. 12 indexed citations
8.
Sun, Yuyun, et al.. (2022). Application of a Novel 68Ga-HER2 Affibody PET/CT Imaging in Breast Cancer Patients. Frontiers in Oncology. 12. 894767–894767. 14 indexed citations
9.
Lin, Mingxi, Yizi Jin, Hong Lv, Xichun Hu, & Jian Zhang. (2022). Incidence and prognostic significance of receptor discordance between primary breast cancer and paired bone metastases. International Journal of Cancer. 152(7). 1476–1489. 2 indexed citations
10.
Jin, Yizi, Mingxi Lin, Zhiguo Luo, Xichun Hu, & Jian Zhang. (2021). Development and validation of a nomogram for predicting overall survival of patients with cancer of unknown primary: a real-world data analysis. Annals of Translational Medicine. 9(3). 198–198. 4 indexed citations
11.
Lin, Mingxi, Yizi Jin, Ziyi Yang, Xichun Hu, & Jian Zhang. (2021). Determination and clinical significance of bone pseudoprogression in hormone receptor-positive metastatic breast cancer. Therapeutic Advances in Medical Oncology. 13. 4277434913–4277434913. 3 indexed citations
12.
13.
14.
Zhang, Jinfeng, Mingxi Lin, Yizi Jin, et al.. (2020). Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia. Breast Cancer Research and Treatment. 182(3). 719–726. 6 indexed citations
15.
16.
Jin, Yizi, et al.. (2020). Inflammatory Myofibroblastic Tumor of Spinal Canal: Brief Case Report. Journal of Neurological Surgery Part A Central European Neurosurgery. 81(3). 264–270. 4 indexed citations
17.
Cui, Hongxia, Yizi Jin, Chen Fang, et al.. (2019). Clinicopathological evidence of hepatitis B virus infection in the development of gastric adenocarcinoma. Journal of Medical Virology. 92(1). 71–77. 26 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tingting Long Breakdown of academic impact, for papers by Cheng Zeng Breakdown of academic impact, for papers by Hui Guo Breakdown of academic impact, for papers by Hsin‐Yu Fang Breakdown of academic impact, for papers by Te‐Mao Li Breakdown of academic impact, for papers by Caixia Sun Breakdown of academic impact, for papers by Pei‐Ling Chi Breakdown of academic impact, for papers by Xiong Li Breakdown of academic impact, for papers by Blake M. Warner
Rankless by CCL
2026